Nada Elbuluk, MD

Title(s)Clinical Associate Professor of Dermatology (Clinician Educator)
SchoolKeck School of Medicine of Usc
Address1450 San Pablo St.
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Princeton University, Princeton, NJBA
    University of Michigan, Ann Arbor, MIMScClinical Research
    University of Michigan, Ann Arbor, MIMDMedicine
    Johns Hopkins, Baltimore, MDDermatology, Residency
    University of Pennsylvania, Philadelphia, PADermatology, Fellowship

    Collapse Overview 
    Collapse Overview
    Dr. Nada Elbuluk is a board-certified dermatologist and Assistant Professor at the USC Keck School of Medicine, Department of Dermatology. She is honored to be a dermatologist at USC and to be able to serve the diverse population of Los Angeles. She is the founder and director of the USC Skin of Color Center and Pigmentary Disorders Clinic. She also serves as the Director of the Dermatology Diversity and Inclusion Program.

    Dr. Elbuluk’s clinical and research interests include general medical and cosmetic dermatology,
    ethnic skin conditions, and pigmentary disorders including vitiligo, melasma, and postinflammatory pigmentation. She performs a variety of procedures including chemical peels, microneedling, lasers, and botox and has expertise in safely performing these procedures in all skin types.

    Dr. Elbuluk received her bachelor’s degree in Psychology from Princeton University where she also minored in Gender Studies and African American Studies. She completed her medical degree at the University of Michigan where she graduated with a Distinction in Research. While there, she received a National Institute of Health award that allowed her to also obtain a Master of Science in Clinical Research from the University of Michigan School of Public Health. She completed her dermatology residency at Johns Hopkins Hospital. Afterwards, she was a fellow and clinical instructor in the Dermatology Department at The University of Pennsylvania. She then spent four years as an Assistant Professor at New York University’s School of Medicine, where she was the founder and director of the pigmentary disorder clinic and served as the Diversity Ambassador for the Department.

    Dr. Elbuluk feels strongly about providing her patients with the highest quality of individualized and compassionate care. She also is passionate about teaching and advancing the field of dermatology through research on pigmentary disorders and ethnic skin conditions. She has received several grants to support her research, which has been published in numerous academic journals. She has lectured both national and internationally on her areas of expertise. She also serves as a media expert for the American Academy of Dermatology and has been interviewed by numerous media outlets including the Washington Post, Health, Women’s Health, Essence, Prevention, Allure, Reader’s Digest, the Huffington Post, SELF, and NBC.com.

    Dr. Elbuluk is a Diplomate of the American Academy of Dermatology and holds professional memberships with the American Academy of Dermatology, the Women’s Dermatologic Society, the American Society for Dermatologic Surgery, and the Skin of Color Society.
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Reply to "The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Skin of Color Consumers". J Drugs Dermatol. 2024 Oct 01; 23(10):905-906. Palepu S, Elbuluk N, Taylor S. PMID: 39361695.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. A Review of Cutaneous Extraintestinal Manifestations of Inflammatory Bowel Disease in Skin of Color. Inflamm Bowel Dis. 2024 Sep 28. Odufalu FD, Gonzalez S, Hurtado ACM, Hsiao J, Xu M, Elbuluk N. PMID: 39340819.
      View in: PubMed   Mentions:    Fields:    
    3. Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantation. J Am Acad Dermatol. 2024 Sep 07. Hamzavi IH, Ganesan AK, Mahmoud BH, Weiss E, Ahmed AM, Robinson D, Goldman MP, Munavalli G, Kahn SA, Huang V, Waibel J, Desai A, Elbuluk N, Desai S, Pandya AG. PMID: 39182674.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African Americans. J Am Acad Dermatol. 2024 Sep 07. Grimes PE, Dias S, Kyei A, Tatarinova TV, Alexis A, Elbuluk N, Drake L, Shapiro J. PMID: 39182675.
      View in: PubMed   Mentions:    Fields:    
    5. Top DEI Topics to Incorporate Into Dermatology Residency Training: An Electronic Delphi Consensus Study. Cutis. 2024 Sep; 114(3):72-75. Encarnación-Cortés VS, Rodriguez I, Rinderknecht FA, Admassu N, Phillips G, Castillo-Valladares H, Tarbox M, Peebles JK, Stratman EJ, Altman EM, Pimentel MA, Elbuluk N, Parekh P, Daveluy S, James W, Kim SJ, Rosmarin D, Kakpovbia E, Silverberg JI, Bowers S, Vasquez R, Worswick SD, Ahmed AM. PMID: 39413328.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Disorders of hyperpigmentation and associated thyroid abnormalities: a retrospective cohort study. Arch Dermatol Res. 2024 Aug 24; 316(8):572. Gonzalez S, Mora Hurtado AC, Syder N, Quarshie C, Ghanshani R, Rodman J, Elbuluk N. PMID: 39180543.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Neuromodulators in Skin of Color: An International Review. Dermatol Surg. 2024 Sep 01; 50(9S):S73-S79. Mora Hurtado AC, Elbuluk N, Taylor SC. PMID: 39196838.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. The State of Skin of Color Centers in the United States: A Cross-Sectional Survey Study. Cutis. 2024 Jul; 114(1):16-20. Montgomery SN, Kerby E, Hurtado ACM, Elbuluk N. PMID: 39159355.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Racial and Ethnic Diversity in Vitiligo Clinical Trials: A Retrospective Cross-Sectional Study Assessing Demographic Reporting of Participants. J Drugs Dermatol. 2024 07 01; 23(7):e164-e166. Holla S, Hurtado ACM, Gonzalez S, Gupta R, Pandya AG, Elbuluk N. PMID: 38954619.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Perception of skin cancer risk and sun protective practices in individuals with vitiligo: a prospective international cross-sectional survey. Arch Dermatol Res. 2024 May 22; 316(5):189. Gonzalez S, Mora Hurtado AC, Syder NC, Rodman J, Elbuluk N. PMID: 38775848; PMCID: PMC11111492.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Differing features of pemphigus in skin of colour versus white skin: A broad-scale cohort study. J Eur Acad Dermatol Venereol. 2024 May 10. Kasperkiewicz M, Elbuluk N, Ngo BT, Kridin K, Ludwig RJ. PMID: 38727614.
      View in: PubMed   Mentions:    Fields:    
    12. Cosmetic injectables in skin of color: A review of uses, safety, and effectiveness of neuromodulators and dermal fillers. J Cosmet Dermatol. 2024 Jul; 23(7):2345-2360. McKenzie S, Wang J, Mora Hurtado AC, Uppal P, Taylor SC, Elbuluk N. PMID: 38553836.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Integrating skin color assessments into clinical practice and research: A review of current approaches. J Am Acad Dermatol. 2024 Feb 09. Harvey VM, Alexis A, Okeke CAV, McKinley-Grant L, Taylor SC, Desai SR, Jaleel T, Heath CR, Kang S, Vashi N, Lester J, Vasquez R, Rodrigues M, Elbuluk N, Hamzavi I, Kwatra SG, Sundaram H, Cobb C, Brown SG, Kohli I, Callender VD. PMID: 38342247.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Cysteamine Isobionic-Amide Complex Versus Kligman's Formula for the Treatment of Melasma: Equal Efficacy and Rapid Onset of Action. J Drugs Dermatol. 2024 02 01; 23(2):9-16. Sachdev M, Grimes PE, Callender V, Hartman CL, Taylor SC, Elbuluk N, Badawi A, Funasaka Y, Lim J, Ng CY, Desai SR. PMID: 38306138.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Psychological comorbidities of vitiligo: a retrospective cross-sectional analysis in an urban population. Arch Dermatol Res. 2023 Dec 04; 316(1):14. Montgomery SN, Syder N, Barajas G, Elbuluk N. PMID: 38047925.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Best practices in the treatment of melasma with a focus on patients with skin of color. J Am Acad Dermatol. 2024 Feb; 90(2):269-279. Desai SR, Alexis AF, Elbuluk N, Grimes PE, Weiss J, Hamzavi IH, Taylor SC. PMID: 37748556.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Racial diversity in academic dermatology: A cross-sectional analysis of Black academic dermatology faculty in the United States. J Am Acad Dermatol. 2024 01; 90(1):182-184. Gonzalez S, Syder N, McKenzie SA, Price KN, Ngo B, Mora Hurtado AC, Rodman J, Elbuluk N. PMID: 37734667.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Rising Interest in Sunscreen for Skin of Color: An Analysis of Google Trends. J Drugs Dermatol. 2023 07 01; 22(7):712-713. Syder NC, Elbuluk N. PMID: 37410040.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Targeting Inflammation in Acne: Current Treatments and Future Prospects. Am J Clin Dermatol. 2023 Sep; 24(5):681-694. Cruz S, Vecerek N, Elbuluk N. PMID: 37328614; PMCID: PMC10460329.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    20. Disorders of Facial Hyperpigmentation. Dermatol Clin. 2023 Jul; 41(3):393-405. Syder NC, Quarshie C, Elbuluk N. PMID: 37236709.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Treatment recommendations for acne-associated hyperpigmentation: Results of the Delphi consensus process and a literature review. J Am Acad Dermatol. 2023 08; 89(2):316-323. Taylor S, Elbuluk N, Grimes P, Chien A, Hamzavi I, Alexis A, Gonzalez N, Weiss J, Kang S, Desai SR. PMID: 36924935.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Radiofrequency and Radiofrequency Microneedling in Skin of Color: A Review of Usage, Safety, and Efficacy. Dermatol Surg. 2023 05 01; 49(5):489-493. Syder NC, Chen A, Elbuluk N. PMID: 36826381.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Pigmented Basal Cell Carcinoma: An Argument for Sub-Classification. J Drugs Dermatol. 2023 02 01; 22(2):217-218. Saizan A, Taylor S, Elbuluk N. PMID: 36745362.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Racial and Ethnic Disparities in Research and Clinical Trials. Dermatol Clin. 2023 Apr; 41(2):351-358. Syder NC, Elbuluk N. PMID: 36933925.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Vitiligo and makeup: analyzing interest and usage trends in the 21st century. Int J Dermatol. 2023 09; 62(9):e505-e506. Syder NC, Elbuluk N. PMID: 36691783.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Skin Manifestations of Complex Regional Pain Syndrome. Cutis. 2022 12; 110(6):E16-E18. Montgomery SNB, Elbuluk N. PMID: 36735983.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color. Part II: Differences in clinical presentation and disparities in cutaneous disorders in skin of color. J Am Acad Dermatol. 2022 12; 87(6):1261-1270. McKenzie S, Brown-Korsah JB, Syder NC, Omar D, Taylor SC, Elbuluk N. PMID: 35817332.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    28. Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color - Part I: Genetic, biologic, and structural differences in skin of color. J Am Acad Dermatol. 2022 12; 87(6):1239-1258. Brown-Korsah JB, McKenzie S, Omar D, Syder NC, Elbuluk N, Taylor SC. PMID: 35809800.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Going Beyond Hydroquinone: Alternative Skin Lightening Agents. Cutis. 2022 06; 109(6):302-304. Syder NC, Elbuluk N. PMID: 35960969.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Clinical decision-making bias in darker skin types: a prospective survey study identifying diagnostic bias in decision to biopsy. Int J Dermatol. 2023 04; 62(4):e252-e253. Krueger L, Hijab E, Latkowski JA, Elbuluk N. PMID: 35388461.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Racial and ethnic disparities in clinical research and the dermatology workforce: Part 2. J Am Acad Dermatol. 2023 Nov; 89(5):895-902. Omar D, Syder N, Brown-Korsah JB, McKenzie S, Elbuluk N, Taylor S. PMID: 35390428.
      View in: PubMed   Mentions: 2     Fields:    
    32. Gaps in medical education curricula on skin of color in medical school, residency, and beyond: Part 1. J Am Acad Dermatol. 2023 Nov; 89(5):885-892. Syder NC, Omar D, McKenzie S, Brown-Korsah JB, Taylor SC, Elbuluk N. PMID: 35390429.
      View in: PubMed   Mentions: 4     Fields:    
    33. Telemedicine Alopecia Assessment: Highlighting Patients With Skin of Color. Cutis. 2022 Jan; 109(1):40-42. Wilson BN, McMichael A, Alexis A, Agbai O, Elbuluk N, Callender V, Burgess CM, Taylor SC. PMID: 35180055.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. Seborrheic macular hypopigmentation: a case series proposing a new pigmentary disorder. J Eur Acad Dermatol Venereol. 2022 05; 36(5):e361-e362. Krueger L, Saizan AL, Meehan SA, Ezzedine K, Hamzavi I, Elbuluk N. PMID: 34927764.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. The Pathogenesis and Management of Acne-Induced Post-inflammatory Hyperpigmentation. Am J Clin Dermatol. 2021 Nov; 22(6):829-836. Elbuluk N, Grimes P, Chien A, Hamzavi I, Alexis A, Taylor S, Gonzalez N, Weiss J, Desai SR, Kang S. PMID: 34468934.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    36. Dermoscopy of acquired pigmentary disorders: a comprehensive review. Int J Dermatol. 2022 Jan; 61(1):7-19. Krueger L, Saizan A, Stein JA, Elbuluk N. PMID: 34235719.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    37. A Multi-Centered Case-Control Study of Vitiligo Support Groups and Quality of Life. J Drugs Dermatol. 2021 Jun 01; 20(6):672-675. Smith ZI, Wang JF, Elbuluk N, Huggins RH, Birnbaum MR, Rzepecki A, Bhatia BK, Kratschmer C, McLellan B, Kutner A. PMID: 34076392.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine. J Headache Pain. 2021 May 17; 22(1):37. Nahas SJ, Hindiyeh N, Friedman DI, Elbuluk N, Kellerman DJ, Foreman PK, Schmidt P. PMID: 34001002; PMCID: PMC8127195.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. A diverse nation calls for a diverse healthcare force. EClinicalMedicine. 2021 Apr; 34:100846. Saizan AL, Douglas A, Elbuluk N, Taylor S. PMID: 33997735; PMCID: PMC8102711.
      View in: PubMed   Mentions: 4  
    40. Direct-to-consumer dermatology-related advertising differs in magazines targeted to women of color: A cross-sectional analysis of top-circulating consumer magazines. Int J Womens Dermatol. 2021 Mar; 7(2):191-194. Wiznia LE, Wang J, Steuer AB, Elbuluk N. PMID: 33937491; PMCID: PMC8072494.
      View in: PubMed   Mentions: 2  
    41. Vitiligo and Melanoma-Associated Vitiligo: Understanding Their Similarities and Differences. Am J Clin Dermatol. 2020 Oct; 21(5):669-680. Cohen BE, Manga P, Lin K, Elbuluk N. PMID: 32468356.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    42. A quantitative analysis of research publications focused on the top chief complaints in patients with skin of color. J Am Acad Dermatol. 2021 Jul; 85(1):241-242. Montgomery SNB, Elbuluk N. PMID: 32800869.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Postinflammatory hypopigmentation: a comprehensive review of treatments. J Dermatolog Treat. 2022 Mar; 33(2):704-708. Madu PN, Syder N, Elbuluk N. PMID: 32643458.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. The digital divide: How COVID-19's telemedicine expansion could exacerbate disparities. J Am Acad Dermatol. 2020 11; 83(5):e345-e346. Bakhtiar M, Elbuluk N, Lipoff JB. PMID: 32682890; PMCID: PMC7365110.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCellsPHPublic Health
    45. The Relevance of Vitamin D Supplementation for People of Color in the Era of COVID-19. J Drugs Dermatol. 2020 Jul 01; 19(7):782-783. Grimes PE, Elbuluk N, Alexis AF. PMID: 33528149.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Evaluating Population Interest in Vitiligo Through an Analysis of Google Trends and Social Media. J Drugs Dermatol. 2020 Jun 01; 19(6):661-665. Montgomery SNB, Elbuluk N. PMID: 32574016.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Why can we see our narrowband UVB lights? J Am Acad Dermatol. 2020 06; 82(6):e251-e252. Soleymani T, Soter NA, Folan LM, Elbuluk N, Cohen DE. PMID: 32109539.
      View in: PubMed   Mentions:    Fields:    
    48. Photolichenoid dermatitis: a presenting sign of human immunodeficiency virus. Cutis. 2019 Oct; 104(4):242-244. Curtiss P, Riley K, Meehan SA, Elbuluk N. PMID: 31809532.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Comorbid diseases of vitiligo: A 10-year cross-sectional retrospective study of an urban US population. J Am Acad Dermatol. 2020 Mar; 82(3):628-633. Hadi A, Wang JF, Uppal P, Penn LA, Elbuluk N. PMID: 31325552.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    50. Frontal fibrosing alopecia: cutaneous associations in women with skin of color. Cutis. 2018 Nov; 102(5):335-338. Krueger L, Svigos K, Brinster N, Elbuluk N. PMID: 30566548.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Deficiency of sun protection advertising exists in consumer magazines across demographic groups and varies by target demographic. J Am Acad Dermatol. 2019 Apr; 80(4):1139-1141. Wiznia LE, Wang J, Steuer AB, Elbuluk N. PMID: 30315819.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    52. International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation. Br J Dermatol. 2019 03; 180(3):574-579. Eleftheriadou V, Hamzavi I, Pandya AG, Grimes P, Harris JE, Huggins RH, Lim HW, Elbuluk N, Bhatia B, Tovar-Garza A, Nahhas AF, Braunberger T, Ezzedine K. PMID: 30030843.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    53. Beyond Traditional Treatment: The Importance of Psychosocial Therapy in Vitiligo. J Drugs Dermatol. 2018 Jun 01; 17(6):688-691. Rzepecki AK, McLellan BN, Elbuluk N. PMID: 29879259.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Disparity in Cutaneous Pigmentary Response to LED vs Halogen Incandescent Visible Light: Results from a Single Center, Investigational Clinical Trial Determining a Minimal Pigmentary Visible Light Dose. J Drugs Dermatol. 2017 Nov 01; 16(11):1105-1110. Soleymani T, Cohen DE, Folan LM, Okereke UR, Elbuluk N, Soter NA. PMID: 29141058.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    55. Melasma: an Up-to-Date Comprehensive Review. Dermatol Ther (Heidelb). 2017 Sep; 7(3):305-318. Ogbechie-Godec OA, Elbuluk N. PMID: 28726212; PMCID: PMC5574745.
      View in: PubMed   Mentions: 54  
    56. The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone. Exp Dermatol. 2017 07; 26(7):637-644. Arowojolu OA, Orlow SJ, Elbuluk N, Manga P. PMID: 28370349; PMCID: PMC5507766.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    57. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients. Dermatol Clin. 2017 Apr; 35(2):117-128. Elbuluk N, Ezzedine K. PMID: 28317521.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    58. Daily indoor light exposure: A spectral analysis of ambient light sources and its relevance to occupational dermatology. J Am Acad Dermatol. 2017 04; 76(4):763-765. Soleymani T, Folan LM, Soter NA, Elbuluk N, Cohen DE. PMID: 28325397.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    59. A Difference in Cutaneous Pigmentary Response to LED Versus Halogen Incandescent Visible Light: A Case Report from a Single Center, Investigational Clinical Trial Determining a Minimal Pigmentary Visible Light Dose. J Drugs Dermatol. 2017 Apr 01; 16(4):388-392. Soleymani T, Soter NA, Folan LM, Elbuluk N, Okereke UR, Cohen DE. PMID: 28403275.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    60. Microneedling: A Comprehensive Review. Dermatol Surg. 2017 Mar; 43(3):321-339. Hou A, Cohen B, Haimovic A, Elbuluk N. PMID: 27755171.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    61. Advances in Vitiligo: An Update on Medical and Surgical Treatments. J Clin Aesthet Dermatol. 2017 Jan; 10(1):15-28. Dillon AB, Sideris A, Hadi A, Elbuluk N. PMID: 28210378; PMCID: PMC5300730.
      View in: PubMed   Mentions: 8  
    62. Lichen planus pigmentosus and lichen planopilaris. Dermatol Online J. 2016 Dec 15; 22(12). Cobos G, Kim RH, Meehan S, Elbuluk N. PMID: 28329547.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    63. Lichen planus pigmentosus. Dermatol Online J. 2016 Dec 15; 22(12). Orme CM, Kim RH, Brinster N, Elbuluk N, Franks AG. PMID: 28329536.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. Common conditions in skin of color. Semin Cutan Med Surg. 2016 Dec; 35(4):184-190. Hadi A, Elbuluk N. PMID: 27917999.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Recent advances in understanding vitiligo. F1000Res. 2016; 5. Manga P, Elbuluk N, Orlow SJ. PMID: 27635239; PMCID: PMC5017284.
      View in: PubMed   Mentions: 24     Fields:    
    66. Infrared irradiation differentially alters collagen metabolism in lightly and darkly pigmented human skin in vivo. J Dermatol Sci. 2016 Jun; 82(3):212-4. Elbuluk N, Wang F, Tran BA, Hammerberg C, Voorhees JJ, Kang S, Fisher GJ. PMID: 27020409.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    67. Microneedling in skin of color: A review of uses and efficacy. J Am Acad Dermatol. 2016 Feb; 74(2):348-55. Cohen BE, Elbuluk N. PMID: 26549251.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    68. Cutaneous Rosai-Dorfman Disease in a Patient with Human Immunodeficiency Virus. Dermatol Online J. 2016 Jan 15; 22(1). Elbuluk N, Egbers R, Taube JM, Wang TS. PMID: 26990470.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    69. Alternative Systemic Treatments for Vitiligo: A Review. Am J Clin Dermatol. 2015 Dec; 16(6):463-74. Cohen BE, Elbuluk N, Mu EW, Orlow SJ. PMID: 26329814.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    70. Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses. Am J Pathol. 2011 Apr; 178(4):1434-41. Nesterovitch AB, Gyorfy Z, Hoffman MD, Moore EC, Elbuluk N, Tryniszewska B, Rauch TA, Simon M, Kang S, Fisher GJ, Mikecz K, Tharp MD, Glant TT. PMID: 21406173; PMCID: PMC3078441.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    71. What is your diagnosis? Multiple cutaneous and uterine leiomyomatosis (Reed Syndrome). Cutis. 2011 Feb; 87(2):65, 76-7. Elbuluk N, Bichakjian CK, Lowe L. PMID: 21416770.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. Erythema nodosum leprosum, Sweet's syndrome, and human immunodeficiency virus may be related through an overlap in immunopathogenesis. Int J Dermatol. 2010 Nov; 49(11):1344-5. Elbuluk N, Martiniuk F, Levis WR. PMID: 20964666.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    73. Retinoic acid 4-hydroxylase inducibility and clinical response to isotretinoin in patients with acne. J Am Acad Dermatol. 2009 Aug; 61(2):252-8. Wang F, Kwak HS, Elbuluk N, Kaczmarek AL, Hamilton T, Voorhees JJ, Fisher GJ, Kang S. PMID: 19525031; PMCID: PMC3103843.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    Nada's Networks
    Concepts (221)
    Derived automatically from this person's publications.
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _